Welcome to Paid Research Studies




  • Conditions:   Retinoblastoma;   Children;   Retinal Neoplasm
    Interventions:   Drug: VP16, carboplatin;   Drug: Melphalan;   Drug: VP16, carboplatin, vincristin;   Drug: Carboplatin + laser day 1 (chemothermotherapy);   Device: Laser (local treatment);   Device: cryoapplication (local treatment);   Radiation: I125 radioactive plaques (local treatment);   Drug: intravitreal Melphalan (local treatment)
    Sponsors:   Institut Curie;   Fondation Rothschild Paris
    Recruiting

  • Condition:   Breast Cancer
    Intervention:   Drug: Abemaciclib
    Sponsors:   Dana-Farber Cancer Institute;   Eli Lilly and Company
    Recruiting

  • Conditions:   Pediatric Solid Tumor;   Germ Cell Tumor;   Retinoblastoma;   Hepatoblastoma;   Wilms Tumor;   Rhabdoid Tumor;   Carcinoma;   Osteosarcoma;   Ewing Sarcoma;   Rhabdomyosarcoma;   Synovial Sarcoma;   Clear Cell Sarcoma;   Malignant Peripheral Nerve Sheath Tumors;   Desmoplastic Small Round Cell Tumor;   Soft Tissue Sarcoma;   Neuroblastoma
    Interventions:   Biological: second generation 4-1BBζ EGFR806-EGFRt;   Biological: second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    Sponsor:   Seattle Children's Hospital
    Recruiting

  • Conditions:   Acute Leukemia;   Adenomatous Polyposis;   Adrenocortical Carcinoma;   AML;   BAP1 Tumor Predisposition Syndrome;   Carney Complex;   Choroid Plexus Carcinoma;   Constitutional Mismatch Repair Deficiency Syndrome;   Diamond-Blackfan Anemia;   DICER1 Syndrome;   Dyskeratosis Congenita;   Emberger Syndrome;   Familial Acute Myeloid Leukemia;   Familial Adenomatous Polyposis;   Fanconi Anemia;   Familial Cancer;   Familial Wilms Tumor;   Familial Neuroblastoma;   GIST;   Hereditary Breast and Ovarian Cancer;   Hereditary Paraganglioma-Pheochromocytoma Syndrome;   Hodgkin Lymphoma;   Juvenile Polyposis;   Li-Fraumeni Syndrome;   Lynch Syndrome;   MDS;   Melanoma Syndrome;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Neuroblastoma;   Neurofibromatosis Type 1;   Neurofibromatosis Type II;   Nevoid Basal Cell Carcinoma Syndrome;   Non Hodgkin Lymphoma;   Noonan Syndrome and Other Rasopathy;   Overgrowth Syndromes;   Pancreatic Cancer;   Peutz-Jeghers Syndrome;   Pheochromocytoma/Paraganglioma;   PTEN Hamartoma Tumor Syndrome;   Retinoblastoma;   Rhabdoid Tumor Predisposition Syndrome;   Rhabdomyosarcoma;   Rothmund-Thomson Syndrome;   Tuberous Sclerosis;   Von Hippel-Lindau Disease
    Intervention:  
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting

  • Conditions:   Retinoblastoma;   Clear Cell Sarcoma;   Renal Cell Carcinoma;   Rhabdoid Tumor;   Wilms Tumor;   Hepatoblastoma;   Neuroblastoma;   Germ Cell Tumors;   Ewings Sarcoma;   Non-rhabdomyosarcoma Soft Tissue Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma
    Interventions:   Drug: Simvastatin;   Drug: Cyclophosphamide;   Drug: Topotecan;   Drug: Myeloid growth factor
    Sponsors:   Emory University;   Children's Healthcare of Atlanta
    Recruiting

  • Conditions:   Acute Myeloid Leukemia;   Acute Lymphoid Leukemia;   Lymphoma;   Neuroblastoma;   Hepatoblastoma;   Retinoblastoma
    Interventions:   Biological: GM-CSF;   Biological: G-CSF;   Biological: GM-CSF and G-CSF
    Sponsor:   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
    Recruiting

  • Conditions:   Burkitt Lymphoma;   Retinoblastoma
    Intervention:   Other: mHealth Case Management System
    Sponsors:   Duke University;   National Cancer Institute (NCI)
    Not yet recruiting

  • Conditions:   Ewing's Family Tumors;   Renal Tumors;   Hepatoblastoma;   Rhabdomyosarcoma;   Soft Tissue Sarcoma;   Primary Malignant Brain Neoplasms;   Retinoblastoma;   Medulloblastoma;   Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET);   Atypical Teratoid/Rhabdoid Tumor (AT/RT);   CNS Tumors;   Germ Cell Tumors
    Interventions:   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Mesna;   Biological: G-CSF;   Drug: Busulfan;   Drug: Melphalan;   Drug: Thiotepa;   Biological: Autologous stem cell infusion;   Radiation: Radiation;   Drug: Carboplatin;   Drug: Paclitaxel;   Procedure: Leukapheresis;   Drug: Anti-seizure prophylaxis;   Drug: Ursodiol
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Recruiting

  • Conditions:   Glioma;   Neuroectodermal Tumors, Primitive;   Wilms Tumor;   Rhabdomyosarcoma;   Sarcoma, Ewing;   Osteosarcoma;   Retinoblastoma
    Interventions:   Drug: Metronomic Cyclophosphamide;   Drug: Thalidomide
    Sponsor:   Washington University School of Medicine
    Recruiting

  • Conditions:   Pediatric Retinoblastoma;   Retinoblastoma
    Interventions:   Other: Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V);   Other: California Verbal Learning Test, Children's Version;   Other: Beery Developmental Test of Visual Motor Integration, 6th edition;   Other: Grooved Pegboard Test;   Other: Behavior Assessment System for Children/Parent Report
    Sponsor:   Memorial Sloan Kettering Cancer Center
    Recruiting

  • Conditions:   Sarcoma;   Endocrine Tumors;   Neuroblastoma;   Retinoblastoma;   Renal Cancer
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Intraocular Retinoblastoma;   Hearing Loss
    Intervention:   Diagnostic Test: Distortion product otoacoustic emission measurement (DPOAE)
    Sponsor:   Memorial Sloan Kettering Cancer Center
    Recruiting

  • Condition:   Retinoblastoma, Recurrent
    Intervention:   Genetic: VCN-01
    Sponsor:   Fundació Sant Joan de Déu
    Recruiting

  • Condition:   Retinoblastoma
    Intervention:   Device: Dynamic contrast-enhanced MRI
    Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
    Recruiting

  • Conditions:   Retinoblastoma;   Cataracts Infantile;   Glaucoma, Congenital;   Leucocoria
    Interventions:   Other: CRADLE;   Other: Red reflex testing
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting

  • Condition:   Retinoblastoma
    Interventions:   Other: Observation;   Drug: Etoposide;   Drug: Vincristine;   Radiation: Orbital irradiation;   Drug: Carboplatin;   Drug: Cyclophosphamide;   Drug: Thiotepa;   Procedure: Cytapheresis;   Procedure: Peripheral bood stem cell transplantation
    Sponsor:   Institut Curie
    Recruiting

  • Condition:   Retinoblastoma
    Interventions:   Drug: Carboplatin;   Drug: Maxitrol®;   Procedure: Focal Therapy;   Procedure: Plaque Radiotherapy
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting

  • Condition:   Retinoblastoma
    Interventions:   Drug: vincristine;   Drug: topotecan;   Drug: filgrastim;   Drug: PEG-filgrastim;   Drug: carboplatin;   Other: focal therapy;   Drug: etoposide;   Drug: cyclophosphamide;   Drug: MESNA;   Drug: doxorubicin;   Procedure: enucleation;   Radiation: external beam radiation or proton beam radiation
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting